| Autor: |
Lewin, Antoine, Tonnetti, Laura, Renaud, Christian, Drews, Steven J., Bloch, Evan M., O'Brien, Sheila F. |
| Předmět: |
|
| Zdroj: |
Vox Sanguinis; Sep2024, Vol. 119 Issue 9, p921-926, 6p |
| Abstrakt: |
Background and Objectives: Trypanosoma cruzi is the etiologic agent of Chagas disease (CD), an anthropozoonosis from the American continent that progresses from an acute phase to an indeterminate phase, followed by a chronic symptomatic phase in around 30% of patients. In countries where T. cruzi is not endemic, many blood transfusion services test blood donors who have stayed in an endemic country ('at‐risk stay')—even if they do not present with other risk factors. However, the efficiency of this approach has been questioned. Materials and Methods: On 18 September 2023, a worldwide survey was distributed among employees of blood transfusion services. The questions mainly pertained to CD's endemicity in the blood services' region, the current testing policy for T. cruzi and the number of confirmed positive results among donors with a prior at‐risk stay alone (i.e., without other risk factors for T. cruzi infection). Results: Twenty‐six recipients completed the survey. Of the 22 (84.6%) blood services that operated in a non‐endemic region, 9 (42.9%) tested donors for T. cruzi, including 8 (88.9%) that considered the travel history or the duration of the stay (alone) in their testing algorithm ('study blood services'). Over 93 years of observation among all study blood services, 2 donations from donors with an at‐risk stay alone and 299 from those with other risk factors were confirmed positive for T. cruzi. Conclusion: The study findings question the utility of testing blood donors who have stayed in an endemic country without other risk factors. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text